This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignee: Sitari Pharma, Inc.. Active years: 2023-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2024
Title: The Innovative Contributions of Sergio G Duron
Introduction
Sergio G Duron is a notable inventor based in La Jolla, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit transglutaminase 2 (TG2). With a total of 2 patents, his work is paving the way for new treatments for various diseases.
Latest Patents
Duron's latest patents focus on transglutaminase 2 (TG2) inhibitors. These patents describe compounds and pharmaceutical compositions that contain such inhibitors, which are crucial for treating diseases or conditions that would benefit from TG2 inhibition. The methods outlined in these patents detail the use of TG2 inhibitors, either alone or in combination with other compounds, to enhance therapeutic outcomes.
Career Highlights
Sergio G Duron is currently associated with Sitari Pharma, Inc., where he continues to innovate and develop new pharmaceutical solutions. His expertise in the field has led to advancements that could significantly impact patient care and treatment options.
Collaborations
Duron collaborates with talented individuals such as David Campbell and Justin Chapman, contributing to a dynamic team focused on groundbreaking research and development in the pharmaceutical industry.
Conclusion
Sergio G Duron's work exemplifies the spirit of innovation in the pharmaceutical field. His contributions through patents and collaborations are set to make a lasting impact on the treatment of diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile